Top Markets
#1 CyberDEX CyberDEX +391.95%
#2 OVERTAKE OVERTAKE +58.99%
#3 Clearpool Clearpool +25.94%
#4 Playnance Playnance +23.93%
#5 deBridge deBridge +22.97%
#6 B3 (Base) B3 (Base) +20.83%
#7 Nillion Nillion +19.56%
#8 AUKI AUKI +19.09%
#9 Codatta Codatta +17.25%
#10 龙虾 (Lobster) 龙虾 (Lobster) +17.03%
Coin of the day
CyberDEX CyberDEX
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Nuformix plc Nuformix plc

Nuformix plc

NFX
Classifica tra le azioni #41014
Nuformix plc, a pharmaceutical company based in the United Kingdom, specializes... Nuformix plc, a pharmaceutical company based in the United Kingdom, specializes in developing therapies for fibrotic diseases and cancer, primarily through the innovative strategy of drug repurposing. Its current development portfolio includes NXP001, which has advanced beyond Phase 1 trials for application in oncology supportive care. Additionally, the company is progressing NXP004, a novel variant of Olaparib, currently in its intellectual property generation stage for oncological indications, and NXP002, which is undergoing pre-clinical evaluation for the treatment of idiopathic pulmonary fibrosis. Nuformix also holds an option agreement with Oxilio Ltd. concerning NXP001 for its oncology applications. Established in 2008, the company maintains its operational base in London.
Prezzo delle azioni
$0.00185055
Capitalizzazione di mercato
$48.29K
Variazione (1 giorno)
-3.55%
Variazione (1 anno)
30.31%
Paese
GB
Scambia Nuformix plc (NFX)

Categoria

Healthcare
Storico del prezzo dell'azione per Nuformix plc (NFX)
Prezzo di chiusura più alto: $0.00 il 2026-09-01

Prezzo di chiusura più basso: $0.04 il 2015-12-01
Storico del prezzo dell'azione di Nuformix plc dal 2015 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2026 (TTM) 0.00%
2025 410.64%
2024 -82.59%
2023 -11.19%
2022 -74.73%
2021 -56.41%
2020 -60.57%
2019 249.10%
2018 -26.41%
2017 -13.50%
2016 17.74%
2015 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $514.89 35.60%
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $182.73 608.53%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $125.92 -4.58%
AU
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $948.14 29.11%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $730.39 7.23%
CH